Purpose and Summary
H.R. 6238, introduced on November 20, 2025, by
Representatives Lauren Underwood (D-IL) and Brian Fitzpatrick
(R-PA), authorizes the Implementing a Maternal Health and
Pregnancy Outcomes Vision for Everyone (IMPROVE) Initiative
within the National Institutes of Health (NIH) for fiscal years
(FY) 2026 through 2031. This legislation advances maternal
health research to reduce preventable causes of maternal
mortality and severe maternal morbidity.
Background and Need for Legislation
In 2024, 649 women in the U.S. died from pregnancy-related
causes.\1\ Severe maternal morbidity (SMM)--serious and
unexpected outcomes associated with pregnancy--annually impact
30,000 in the U.S. and rate of SMM has increased over the past
decade.\2\ The Centers for Disease Control and Prevention
estimates that over 80 percent of pregnancy-related death and
about half of SMM events could be preventable.\3\ Women in the
United States face higher maternal mortality rates than other
high-income nations.\4\ Black and Native American women, as
well as individuals in rural areas, are disproportionately
affected by severe maternal morbidity and mortality.\5\
---------------------------------------------------------------------------
\1\U.S. Department of Health and Human Services, Office of the
Assistant Secretary for Planning and Evaluation, Report to Congress,
Addressing the Maternal Health Crisis in the United States: An Update
from the U.S. Department of Health and Human Services (Jul. 2024),
https://aspe.hhs.gov/sites/default/files/documents/
3c79dd97c5a9330173bd033f30fb7ba6/rtc-
maternal-health.pdf.
\2\Id.
\3\Id.
\4\Evan D. Gumas et al., Maternal and Child Mortality: How Do U.S.
States Compare Internationally?, The Commonwealth Fund (Oct. 1, 2025),
https://www.commonwealthfund.org/
publications/issue-briefs/2025/oct/maternal-child-mortality-how-do-us-
states-compare-
internationally?utm_source=newsletter&utm_medium=email&utm_campaign=news
letter_
axiosvitals&stream=top.
\5\U.S. Department of Health and Human Services, National
Institutes of Health, IMPROVE Initiative, Implementing a Maternal
health and Pregnancy Outcomes Vision for Everyone (IMPROVE) Initiative
(last accessed Jun. 2026), https://www.nichd.nih.gov/research/
supported/IMPROVE.
---------------------------------------------------------------------------
Access to maternal health care has been a challenge for
many women as roughly 35 percent of U.S. counties are
considered maternity care deserts and over half of U.S.
counties lacked a hospital or birth center providing obstetric
care.\6\ Further, reduced access to obstetric care has been
correlated with higher rates of maternal illness and death.\7\
Launched by the NIH in 2019, the IMPROVE Initiative lacked a
dedicated and consistent funding source, threatening long-term
research outcomes. The act provides an authorization for
continuous annual funding to support sustained, multi-year
research. H.R. 6238 authorizes the IMPROVE Initiative and
funding to advance maternal health research, support the
integration of disproportionally affected populations affected
by high rates of maternal morbidity and mortality, and
ultimately reduce preventable causes of maternal mortality and
morbidity.
---------------------------------------------------------------------------
\6\Health Resources & Services Administration, How We Improve
Maternal Health (Feb. 2025), https://www.hrsa.gov/maternal-health#3.
\7\Sebastian Z. Ramos et al., Maternal care deserts and risk of
maternal morbidity in term pregnancies, American Journal of Obstetrics
& Gynecology (Jan. 2026), https://www.ajogmfm.org/article/S2589-
9333(25)00220-4/abstract.
---------------------------------------------------------------------------
Committee Action
On April 21, 2026, the Subcommittee on Health held a
hearing related to H.R. 6238. The title of the hearing was,
``The Fiscal Year 2027 Department of Health and Human Services
Budget.'' The Subcommittee received testimony from:
The Honorable Robert F. Kennedy, Jr.,
Secretary, U.S. Department of Health and Human
Services.
On May 21, 2026, the full Committee on Energy and Commerce
met in open markup session and ordered H.R. 6238, as amended,
favorably reported to the House by a record vote of 46 yeas and
0 nays.
Committee Votes
Clause 3(b) of rule XIII requires the Committee to list the
record votes on the motion to report legislation and amendments
thereto. The following reflects the record votes taken during
the Committee consideration:
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
Oversight Findings and Recommendations
Pursuant to clause 2(b)(1) of rule X and clause 3(c)(1) of
rule XIII, the Committee held a hearing and made findings that
are reflected in this report.
New Budget Authority, Entitlement Authority, and
Tax Expenditures
Pursuant to clause 3(c)(2) of rule XIII, the Committee
finds that H.R. 6238 would result in no new or increased budget
authority, entitlement authority, or tax expenditures or
revenues.
Congressional Budget Office Estimate
Pursuant to clause 3(c)(3) of rule XIII, at the time this
report was filed, the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974 was not available.
Federal Mandates Statement
The Committee adopts as its own the estimate of Federal
mandates prepared by the Director of the Congressional Budget
Office pursuant to section 423 of the Unfunded Mandates Reform
Act.
Statement of General Performance Goals and Objectives
Pursuant to clause 3(c)(4) of rule XIII, the general
performance goal or objective of this legislation is to support
research to reduce preventable maternal deaths and severe
maternal morbidity, improve maternal health at every stage of
pregnancy, and address disparities in maternal outcomes.
Duplication of Federal Programs
Pursuant to clause 3(c)(5) of rule XIII, no provision of
H.R. 6238 is known to be duplicative of another Federal
program, including any program that was included in a report to
Congress pursuant to section 21 of Public Law 111-139 or the
most recent Catalog of Federal Domestic Assistance.
Related Committee and Subcommittee Hearings
Pursuant to clause 3(c)(6) of rule XIII, the following
related hearing was used to develop or consider H.R. 6238:
On April 21, 2026, the Subcommittee on
Health held a hearing on H.R. 6238. The title of the
hearing was ``The Fiscal Year 2027 Department of Health
and Human Services Budget.'' The Subcommittee received
testimony from:
The Honorable Robert F. Kennedy,
Jr., Secretary, U.S. Department of Health and
Human Services.
Committee Cost Estimate
Pursuant to clause 3(d)(1) of rule XIII, the Committee
adopts as its own the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974. At the time this report was
filed, the estimate was not available.
Earmark, Limited Tax Benefits, and Limited Tariff Benefits
Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the
Committee finds that H.R. 6238 contains no earmarks, limited
tax benefits, or limited tariff benefits.
Advisory Committee Statement
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
Applicability to Legislative Branch
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
Section-by-Section Analysis of the Legislation
Section 1. Short title
Section 1 provides the short title of ``NIH Implementing a
Maternal health and PRegnancy Outcomes Vision for Everyone'' or
the ``NIH IMPROVE Act.''
Section 2. IMPROVE Initiative
Section 2 reauthorizes the IMPROVE Initiative through 2031.
The IMPROVE Initiative promotes research into the reduction of
preventable causes driving maternal mortality and severe
maternal morbidity and health disparities in maternal health
outcomes, as well as improve women's health throughout the
timespan of their pregnancy.
Changes in Existing Law Made by the Bill, as Reported
In compliance with clause 3(e) of rule XIII of the Rules of
the House of Representatives, changes in existing law made by
the bill, as reported, are shown as follows (new matter is
printed in italics and existing law in which no change is
proposed is shown in roman):
PUBLIC HEALTH SERVICE ACT
* * * * * * *
TITLE IV--NATIONAL RESEARCH INSTITUTES
* * * * * * *
Part B--General Provisions Respecting National
Research Institutes
* * * * * * *
SEC. 409K. IMPROVE INITIATIVE.
(a) In General.--The Director of NIH shall continue to carry
out a program to improve maternal health outcomes, to be known
as the Implementing a Maternal health and PRegnancy Outcomes
Vision for Everyone Initiative or the ``IMPROVE Initiative''
(referred to in this section as the ``Initiative'').
(b) Objectives.--The Initiative shall--
(1) advance research to--
(A) reduce preventable causes of maternal
mortality and severe maternal morbidity;
(B) reduce health disparities related to
maternal health outcomes, including such
disparities associated with populations with
disproportionately high rates of maternal
mortality and severe maternal morbidity
relative to the national rate; and
(C) improve health for pregnant and
postpartum women before, during, and after
pregnancy;
(2) use an integrated approach to understand the
factors, including biological, behavioral, and other
factors, that affect maternal mortality and severe
maternal morbidity by building an evidence base for
improved outcomes in specific regions of the United
States; and
(3) target health disparities associated with
maternal mortality and severe maternal morbidity by--
(A) implementing and evaluating community-
based interventions for disproportionately
affected women; and
(B) identifying risk factors and the
underlying biological mechanisms associated
with leading causes of maternal mortality and
severe maternal morbidity in the United States.
(c) Implementation.--The Director of NIH may award grants or
enter into contracts, cooperative agreements, or other
transactions to carry out this section.
(d) Authorization of Appropriations.--There is authorized to
be appropriated to carry out this section $63,400,000 for each
of fiscal years 2026 through 2030.
* * * * * * *
[all]